QUOTE
Seattle Genetics, Inc. (SGEN)
$
18.50
 $0.17 (0.93%) Jan 26
|
21823 30th Drive SE
,
Bothell,
WA
98021
,
USA
+1-425-527-4000
http://www.seattlegenetics.com |
|
|
| PRICES |
| Open |
Volume |
| 18.49 |
2.39M |
| High |
Low |
| 19.30 |
18.27 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| 2060 |
12,000 |
| 52wk High |
52wk Low |
| 22.28 |
12.67 |
|
| RATIOS |
| P/E |
EPS |
| n/a |
n/a |
| BV |
P/BV |
| 1.45 |
12.76 |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| n/a |
n/a |
| Shares |
Inst Owner |
| 111.34 |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of USD)
|
| |
2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
| Income statement |
| Total Revenue |
$5.07 | $6.70 | $9.76 | $10.01 | $22.42 | $35.24 | $51.97 | $107.47 |
| Oprating Income |
$-23.26 | $-37.67 | $-32.07 | $-40.20 | $-55.65 | $-91.79 | $-84.86 | $-68.20 |
| Net Income |
$-22.09 | $-35.44 | $-29.43 | $-36.02 | $-48.93 | $-85.50 | $-81.68 | $-66.27 |
| Balance Sheet |
| Total Assets |
$82 | $119.11 | $90.02 | $97.69 | $148.53 | $187.72 | $388.33 | $329.94 |
| Total Equity |
$74.88 | $103.83 | $75.46 | $88.23 | $53.99 | $79.02 | $206.20 | $161.52 |
| Total Liabilities |
$7.12 | $15.28 | $14.56 | $9.46 | $94.54 | $108.70 | $182.13 | $168.42 |
| Cash Flow |
| Oprating |
$-17.72 | $-23.28 | $-25.47 | $-35.18 | $39.83 | $-62.63 | $-62.63 | $-61.78 |
| Investing |
$-30.84 | $-40.33 | $25.83 | $-10.76 | $4.07 | $-67.83 | $-67.83 | $-147.42 |
| Financing |
$49 | $63.63 | $1.15 | $43.92 | $6.60 | $101.61 | $101.61 | $196.89 |
| Net Cash Change |
$0.44 | $0.02 | $1.51 | $-2.02 | $50.51 | $-28.84 | $-28.84 | $-12.31 |
|
Earning Call Calender
|
| 2009 | 2008 |
2007 |
2006 |
|
05 February 2009
23 April 2009
23 July 2009
22 October 2009
|
07 February 2008
24 April 2008
22 July 2008
23 October 2008
|
06 February 2007
24 April 2007
13 June 2007
25 July 2007
23 October 2007
|
25 April 2006
25 July 2006
| |
|
| Earning Call Summary |
Transcripts |
| |
|
Management
|
|
Executive |
Title |
|
Clay B. Siegall |
Interim Chairman of the Board, President, Chief Executive Officer | |
|
Todd Simpson |
Chief Financial Officer |
|
Eric L. Dobmeier |
Chief Business Officer |
|
Thomas C. Reynolds |
Chief Medical Officer |
|
Morris Z. Rosenberg |
Senior Vice President - Development |
|
|
|
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites. Market data: BATS Exchange. Inc
